Colombo (Information 1st) – The Sri Lanka Chamber of the Pharmaceutical Business (SLCPI) has raised issues over media and social media stories stating that the Minister of Well being obtained cupboard approval to buy numerous pharmaceutical merchandise to be used within the well being sector from two producers in India on an pressing foundation.
It highlighted that the stories particularly said that neither the manufacturing websites nor the merchandise to be bought are registered with the Nationwide Medicines Regulatory Authority (NMRA), which is the only real and ultimate authority that determines what prescription drugs are to be imported and used within the nation.
In a letter addressed to the NMRA, the SLCPI quoted information stories stating that the Well being Minister had personally visited India in relation to procuring these merchandise and the settlement has been finalized.
“Such actions give rise to critical issues within the business and units a harmful precedent,” the SLCPI said.
It additionally questioned whether or not such actions have been consistent with the NMRA Act of 2015.
The Sri Lanka Chamber of the Pharmaceutical Business sought clarification relating to the media stories and raised its objections in opposition to such actions whether it is true.
See letter under:
Newest Information
